STING1 and colon carcinoma: To investigate the role of STING expression by non-tumor cells during anti-tumor immune responses potentiated by ICB therapy, we established therapeutic treatment conditions in B16F10 melanoma and MC38 colon carcinoma tumor models that led to reproducible inhibition of tumor growth.